Actively Recruiting
Study of Personalized mRNA Vaccine iNeo-Vac-R01 with Standard First-Line Treatment in Adults Aged 18 to 75 with Advanced Digestive System Cancers
Led by Sir Run Run Shaw Hospital · Updated on 2023-09-11
20
Participants Needed
1
Research Sites
17 weeks
Total Duration
AI-Summary
What This Trial Is About
Researchers are evaluating the safety, feasibility, and efficacy of a personalized mRNA vaccine called iNeo-Vac-R01 combined with standard first-line treatment in adults with advanced digestive system cancers. This phase 1, single-center, open-label, single-arm study focuses on patients with locally advanced or metastatic digestive system neoplasms who have measurable disease and meet specific health criteria. Participants will first receive at least four cycles of standard first-line treatment following clinical guidelines. After this, they will receive the personalized mRNA vaccine iNeo-Vac-R01 via intramuscular injection on the first day of each 21-day cycle for up to nine cycles at a dose determined during the dose escalation phase. This combination treatment aims to assess both the vaccines safety and immune response alongside the standard therapy. Throughout the study, participants will undergo evaluations including monitoring for adverse events, tumor response assessments, and immune system measurements such as neoantigen-specific T cell response and cytokine levels. The primary safety outcome will be recorded 21 days after the last vaccine dose, with long-term follow-up of survival and disease control over three years. Other assessments include heart function, organ function tests, and genetic analyses from tumor tissue or sequencing data. The study is expected to continue until the end of 2027.
CONDITIONS
Brief Title
Clinical Study of Personalized mRNA Vaccine Encoding Neoantigen in Combination With Standard First-line Treatment in Subjects With Advanced Digestive System Neoplasms
Research Team
X
Xiujun Cai, MD
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here